(Q40373597)

19 September 2017

title

Successive clinical trials for childhood acute myeloid leukemia at St Jude Children's Research Hospital, from 1980 to 2000. (English)

1 reference

19 September 2017

1 reference

acute myeloid leukemia

1 reference

childhood acute myeloid leukemia

inferred from title

1 reference

Ribeiro RC

1

1 reference

19 September 2017

Razzouk BI

2

1 reference

19 September 2017

Pounds S

3

1 reference

19 September 2017

Hijiya N

4

1 reference

19 September 2017

Pui CH

5

1 reference

19 September 2017

Rubnitz JE

6

1 reference

19 September 2017

publication date

1 December 2005

1 reference

19 September 2017

1 reference

19 September 2017

volume

19

1 reference

19 September 2017

issue

12

1 reference

19 September 2017

page(s)

2125-2129

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403872

19 September 2017

exact match

0 references

cites work

Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

Impact of addition of maintenance therapy to intensive induction and consolidation chemotherapy for childhood acute myeloblastic leukemia: results of a prospective randomized trial, LAME 89/91. Leucámie Aiqüe Myéloïde Enfant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

Late effects of chemotherapy compared to bone marrow transplantation in the treatment of pediatric acute myeloid leukemia and myelodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

Clinical significance of central nervous system involvement at diagnosis of pediatric acute myeloid leukemia: a single institution's experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

Favorable impact of the t(9;11) in childhood acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--a statistician's view

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

Survival from acute non-lymphocytic leukaemia (ANLL) and chronic myeloid leukaemia (CML) in European children since 1978

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

Acute nonlymphocytic leukemia in 171 children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

7 January 2021

Treatment of acute myelogenous leukemia in children and adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

7 January 2021

Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

7 January 2021

Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

7 January 2021

Early intensification of chemotherapy for childhood acute nonlymphoblastic leukemia: improved remission induction with a five-drug regimen including etoposide.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

7 January 2021

Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

7 January 2021

Late effects of treatment in survivors of childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

7 January 2021

Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

7 January 2021

Attitudes of terminally ill cancer patients about euthanasia and assisted suicide: predominance of psychosocial determinants and beliefs over symptom distress and subsequent survival.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

7 January 2021

Hematological malignancies with t(9;11)(p21-22;q23)--a laboratory and clinical study of 125 cases. European 11q23 Workshop participants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

7 January 2021

Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403872

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403872

1 reference

Dimensions Publication ID

19 September 2017

1010915068

0 references

1 reference